Nyumbani › Leukemia ya Lymphoblastic ya Ghafla › Texas
Majaribio ya kliniki ya Leukemia ya Lymphoblastic ya Ghafla katika jimbo la Texas
Masomo 30 ya Leukemia ya Lymphoblastic ya Ghafla yanatafuta washiriki katika vituo vya jimbo la Texas.
Miji katika jimbo la Texas
Maandishi rasmi ya utafiti (Kiingereza)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
InaajiriHatua 1
Hadi umri 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT01853631Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
InaajiriUtafiti wa uchunguzi
Umri 0 hadi 38 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- University of Texas MD Anderson Cancer Center, Houston
InaajiriHatua 1
Umri 12 hadi 78 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
InaajiriHatua 2
6 Months · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Texas Children's Hospital, Houston
InaajiriUtafiti wa uchunguzi
4 Weeks – 18 Years · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- MD Anderson Cancer Center, Houston
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT06308588A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Methodist Children's Hospital, San Antonio
InaajiriHatua 1
Umri 0 hadi 18 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06173518First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- na zaidi ya 10
InaajiriHatua 1/2
Hadi umri 22 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- University of Texas, Southwestern, Dallas
- Baylor Texas Children's Hospital, Houston
InaajiriHatua 2
Umri 7 hadi 25 · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT05082519A Study of CTD402 in T-ALL/LBL Patients
- MD Anderson Cancer Center, Houston
InaajiriHatua 1/2
Umri 1 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT07070219Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Baylor College of Medicine Houston, Houston
- The University of Texas Health Science Center at San Antonio, San Antonio
InaajiriUtafiti wa uchunguzi
1 Day – 17 Years · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT06274788Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
- The University of Texas M. D. Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Ago 2026 · NCT07053059Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- M D Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 15 na zaidi · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT03136146Personalized NK Cell Therapy in CBT
- M D Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 15 hadi 80 · Jinsia zote · Imesasishwa 30 Jul 2026 · NCT02727803Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, Houston
InaajiriHatua 1/2
Umri 16 na zaidi · Jinsia zote · Imesasishwa 20 Jul 2026 · NCT07155226Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Houston
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- na zaidi ya 5
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- MD Anderson Cancer Center (Data Collection Only), Houston
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- MD Anderson, Houston
- University of Texas Health Science Center San Antonio, San Antonio
InaajiriHatua 1/2
Hadi umri 1 · Jinsia zote · Imesasishwa 3 Jun 2026 · NCT05848687Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
- University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory, Arlington
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Mei 2026 · NCT06727942Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- M D Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Mei 2026 · NCT03263572Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 18 Mei 2026 · NCT01790152Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
InaajiriHatua 1
Umri 13 na zaidi · Jinsia zote · Imesasishwa 5 Mei 2026 · NCT04771572A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1501, Houston
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Apr 2026 · NCT06051409A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- MDACC, Houston
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 24 Mac 2026 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
InaajiriHatua 2
Umri 18 hadi 66 · Jinsia zote · Imesasishwa 17 Mac 2026 · NCT06859424Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- University of Texas MD Anderson Cancer Center, Houston
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Nov 2025 · NCT04260022Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Texas, Southwestern, Dallas
- Cook Children's Hospital, Fort Worth
- Texas Children's Hospital/Baylor College of Medicine, Houston
InaajiriHatua 1
Umri 1 hadi 21 · Jinsia zote · Imesasishwa 6 Des 2024 · NCT05476770Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.